TRANSACTION REPORT · SEC DISCLOSURES
Deal notes
Not yet verifiedClosing confirmation
Closing has not been confirmed in the reviewed sources. This record does not establish that funding was received.
Gross proceeds$3.1M
Offering price$2.04
Discount to prior close-0.5%
Warrant coverage—
Placement agent / underwriterDawson James Securities, Inc.
Transaction overview
01Glucotrack, Inc. announced a $3.1M best-efforts public offering at $2.04 per share. Dawson James Securities, Inc. acted as placement agent for the financing.
- Financing type
- Best-Efforts Public Offering
- Announcement date
- Sep 24, 2026
- Pricing date
- Sep 24, 2026
- Closing date
- —
- Filing date
- Sep 24, 2026
- Status
- Priced
- Market cap before announcement
- $451,053.82
- Prior closing price
- $2.03
- Raise as % of market cap
- 687.3%
Market data · FMP
- Historical market cap
- $451,053.82
- Market date
- Sep 23, 2026
- Closing price
- $2.03
- Latest reported shares outstanding
- 798,143
- Latest reported float shares
- 641,159
- Share-data date
- Sep 29, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.
Financial Modeling Prep ↗Financing terms
02Equity
- Common shares issued
- 169,388
- Price per share
- $2.04
- Pre-funded warrants
- 1,350,220
- Pre-financing shares disclosed in filing
- —
- Shares outstanding after financing
- —
Fees & transaction economics
03- Placement agent / underwriting fee
- 8%
- Agent fee amount
- $248,000
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
Transaction participants
04Investor names: —
Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
EX-10.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗EX-10.2 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗EX-10.3 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗EX-4.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗EX-5.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗EX-99.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗8-K · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗424B5 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗FMP historical market data · GCTKMarket data · Sep 23, 2026
Open source ↗Filing evidence & original calculations
agent Fee Percent
8
a cash fee equal to 8% of the aggregate gross proceeds of this offering.Original source ↗
type
Best-Efforts Public Offering
today announced the pricing of a “best efforts” public offeringOriginal source ↗
market Cap
FMP reported market cap; as of 2026-09-23.
{"provider": "FMP", "symbol": "GCTK", "date": "2026-09-23", "marketCap": 451053.82}Original source ↗